Short communication · 16 Sep 2020
Conference abstractPublished 16 Feb 2019
Comparison between the efficacies of pomegranate with different combinations against development of parkinsonism using rotenone model in rats
Al Azhar University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Parkinson’s disease (PD) is a geriatric neurodegenerative disorder marked by the gradual loss of the ability to control physical movements. Exposure to different environmental agents including rotenone (RT) has been linked to increased degeneration and risk of PD. The gold standard effective therapy in PD is L-dopa despite its long-term treatment side effects. In medical folklore, Pomegranate (POM) has been extensively referenced due to its dopaminergic neuroprotective effect while Vinpocetine (VIN) is claimed to enhance brain neurotransmitter, glucose, and oxygen consumption as well as cerebral blood flow. Propolis has been also demonstrated for treatment and prevention of PD while Cocoa can reduce associated symptoms as stress, depression and promote better memory. Objective: To evaluate and compare the efficacy of POM together with each of VIN, Propolis, Cocoa or L-dopa with L-dopa alone using RT-induced PD rat model. Methods: Rats were divided into six groups: one normal and five RT model groups. One of RT (2.5mg/kg SC) groups served as non-treated PD model while the others were treated with either L-dopa (10mg/kg PO) or with POM (150mg/kg PO) together with each of the following; Vin (20mg/kg PO), Propolis (300mg/kg PO), Cocoa (24mg/kg PO) or L-dopa (10mg/kg PO) all for 19 days. Motor and cognitive performances were examined using three tests (catalepsy, open-field, Y-maze). Striatal dopamine, norepinephrine, serotonin, and acetylcholinesterase were assessed as well as mitochondrial complex-1, MDA, SOD, TAC, IL-1β, TNF-α, and caspase-3 expression. In addition, histopathological examinations of different brain regions were also determined. Results: Concurrent treatment with L-dopa alone or with all POM combination groups ameliorated the impairments in locomotor activities as well as cognition and attenuated the depletions in monoamines and mitochondrial complex-1 contents. In addition, the elevations in acetylcholinesterase activity, oxidative stress, and inflammatory markers as well as caspase-3 expression induced by RT were also decreased. Conclusion: Combinations of POM with each of VIN, Propolis or Cocoa have beneficial effects against the development of PD and represent a promising disease-modifying therapy even without given as an adjuvant to L-dopa, consequently can be recommended in protection or in treatment course especially when given early.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 20 Dec 2016
Dopamine D1 and D2 receptor subtypes functional regulation in unilateral rotenone lesioned Parkinsons rat model: Effect of serotonin, dopamine and norepinephrine
Conference abstract · 5 Dec 2016
Dopamine D1 and D2 receptor subtypes functional regulation in unilateral rotenone lesioned Parkinson’s rat model: Effect of serotonin, dopamine and norepinephrine
Conference abstract · 3 Oct 2016
Dopamine D1 and D2 receptor subtypes functional regulation in unilateral rotenone lesioned parkinson’s rat model: effect of serotonin, dopamine and norepinephrine
Conference abstract · 16 Feb 2019
Comparison between the efficacy of vinpocetine, pomegranate, vitamin b complex, vitamin e in providing protection against parkinsonian syndrome induced by manganese in rats
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Azza A Ali”
